Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001144204-15-030939
Filing Date
2015-05-15
Accepted
2015-05-14 20:10:00
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 v410737_s3.htm S-3 202355
2 EXHIBIT 4.1 v410737_ex4-1.htm EX-4.1 1915
3 EXHIBIT 5.1 v410737_ex5-1.htm EX-5.1 12538
4 EXHIBIT 23.1 v410737_ex23-1.htm EX-23.1 2623
5 GRAPHIC image_002.jpg GRAPHIC 4248
6 GRAPHIC image_003.gif GRAPHIC 226778
7 GRAPHIC image_004.gif GRAPHIC 34566
  Complete submission text file 0001144204-15-030939.txt   587059
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
PLASMATECH BIOPHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-204179 | Film No.: 15865010
SIC: 2834 Pharmaceutical Preparations